兰州大学机构库
International expert consensus on diagnosis and treatment of lung cancer complicated by chronic obstructive pulmonary disease
2023-08
Online publication date2023-08
Source PublicationTranslational Lung Cancer Research   Impact Factor & Quartile
ISSN2218-6751 ; 2226-4477
EISSN2226-4477
Volume12Issue:8Pages:1661-1701
page numbers41
AbstractBackground: Lung cancer combined by chronic obstructive pulmonary disease (LC-COPD) is a common comorbidity and their interaction with each other poses significant clinical challenges. However, there is a lack of well-established consensus on the diagnosis and treatment of LC-COPD. Methods: A panel of experts, comprising specialists in oncology, respiratory medicine, radiology, interventional medicine, and thoracic surgery, was convened. The panel was presented with a comprehensive review of the current evidence pertaining to LC-COPD. After thorough discussions, the panel reached a consensus on 17 recommendations with over 70% agreement in voting to enhance the management of LC-COPD and optimize the care of these patients. Results: The 17 statements focused on pathogenic mechanisms (n=2), general strategies (n=4), and clinical application in COPD (n=2) and lung cancer (n=9) were developed and modified. These statements provide guidance on early screening and treatment selection of LC-COPD, the interplay of lung cancer and COPD on treatment, and considerations during treatment. This consensus also emphasizes patient-centered and personalized treatment in the management of LC-COPD. Conclusions: The consensus highlights the need for concurrent treatment for both lung cancer and COPD in LC-COPD patients, while being mindful of the mutual influence of the two conditions on treatment and monitoring for adverse reactions.
KeywordLung cancer chronic obstructive pulmonary disease (COPD) concurrent treatment
PublisherAME PUBLISHING COMPANY
DOI10.21037/tlcr-23-339
Indexed BySCIE
Language英语
WOS Research AreaOncology ; Respiratory System
WOS SubjectOncology ; Respiratory System
WOS IDWOS:001063484800001
Original Document TypeArticle
PMID 37691866
Citation statistics
Cited Times:3[WOS]   [WOS Record]     [Related Records in WOS]
Document Type期刊论文
Identifierhttps://ir.lzu.edu.cn/handle/262010/568210
Collection兰州大学
第一临床医学院
Corresponding AuthorLi, Shuben; Li, Shiyue; Chen, Liang'an; Chen, Rongchang
Affiliation
1.Guangzhou Med Univ, Affiliated Hosp 1, Natl Ctr Resp Med,Natl Clin Res Ctr Resp Dis, State Key Lab Resp Dis,Guangzhou Inst Resp Hlth, Guangzhou, Peoples R China;
2.Chinese Peoples Liberat Army PLA Gen Hosp, Dept Resp & Crit Care Med, Beijing, Peoples R China;
3.Cent South Univ, Xiangya Hosp, Xiangya Canc Ctr, Dept Resp Med, Changsha, Peoples R China;
4.Sichuan Univ, West China Hosp, Dept Resp & Crit Care Med, Chengdu, Peoples R China;
5.Army Med Univ, Dept Resp Med, Xinqiao Hosp, Chongqing, Peoples R China;
6.Peking Univ Third Hosp, Dept Resp & Crit Care Med, Beijing, Peoples R China;
7.Cent South Univ, Xiangya Hosp 2, Dept Resp & Crit Care Med, Changsha, Peoples R China;
8.Peking Univ First Hosp, Dept Resp & Crit Care Med, Beijing, Peoples R China;
9.Jiaotong Univ, Shanghai Chest Hosp, Dept Resp Med, Shanghai, Peoples R China;
10.Huazhong Univ Sci & Technol, Tongji Hosp, Dept Oncol, Wuhan, Peoples R China;
11.Second Mil Med Univ, Shanghai Changhai Hosp, Dept Pulm & Crit Care Med, Shanghai, Peoples R China;
12.Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Dept Med Oncol,Canc Ctr, Guangzhou, Peoples R China;
13.Inner Mongolia Med Univ, Div Resp Med, Affiliated Hosp, Hohhot, Peoples R China;
14.Shanghai Jiao Tong Univ, Dept Resp, Ruijin Hosp, Sch Med, Shanghai, Peoples R China;
15.Second Mil Med Univ, Changhai Hosp, Dept Resp Med, Shanghai, Peoples R China;
16.Army Med Univ, Daping Hosp, Dept Pulm & Crit Care Med, Chongqing, Peoples R China;
17.Fudan Univ, Zhongshan Hosp, Dept Resp Med, Shanghai, Peoples R China;
18.Chinese Peoples Liberat Army PLA Gen Hosp, Dept Med Oncol, Beijing, Peoples R China;
19.Huazhong Univ Sci & Technol, Union Hosp, Dept Resp & Crit Care Med, NHC Key Lab Pulm Dis,Tongji Med Coll, Wuhan, Peoples R China;
20.Zhejiang Univ Med, Affiliated Hosp 2, Dept Resp Med, Hangzhou, Peoples R China;
21.Shanghai Dongfang Hosp, Dept Resp Med, Shanghai, Peoples R China;
22.Zhejiang Univ, Dept Resp & Crit Care Med, Affiliated Hosp 2, Key Lab Resp Dis Zhejiang Prov,Sch Med, Hangzhou, Peoples R China;
23.Univ Chinese Acad Sci, Zhejiang Canc Hosp, Dept Internal Med, Canc Hosp, Hangzhou, Peoples R China;
24.Fujian Canc Hosp, Dept Thorac Oncol, Fuzhou, Peoples R China;
25.Fujian Med Univ Canc Hosp, Fuzhou, Peoples R China;
26.Capital Med Univ, Beijing Tongren Hosp, Dept Resp & Crit Care Med, Beijing, Peoples R China;
27.Lanzhou Univ, Dept Gerontal Resp Med, Hosp 1, Lanzhou, Peoples R China;
28.Gen Hosp Chinese PLA, Dept Oncol, Beijing, Peoples R China;
29.Nanjing Univ, Jinling Hosp, Dept Resp Med, Sch Med, Nanjing, Peoples R China;
30.Soochow Univ, Affiliated Hosp 1, Dept Resp Med, Suzhou, Peoples R China;
31.Tianjin Chest Hosp, Dept Resp & Crit Care Med, Tianjin, Peoples R China;
32.Tongji Univ, Dept Med Oncol, Shanghai Pulm Hosp, Thorac Canc Inst,Sch Med, Shanghai, Peoples R China;
33.Capital Med Univ, Beijing Chao Yang Hosp, Dept Resp & Crit Care Med, Beijing, Peoples R China;
34.Suzhou Univ, Affiliated Hosp 2, Dept Resp Med, Suzhou, Peoples R China;
35.Tongji Univ, Sch Med, Dept Med Oncol, Shanghai Pulm Hosp, Shanghai, Peoples R China;
36.Southern Med Univ, Nanfang Hosp, Dept Resp & Crit Care Med, Guangzhou, Peoples R China;
37.Inner Mongolia Autonomous Reg Peoples Hosp, Dept Resp & Crit Care Med, Hohhot, Inner Mongolia, Peoples R China;
38.Qingdao Municipal Hosp, Dept Resp Med, Qingdao, Peoples R China;
39.Zhengzhou Univ, Henan Canc Hosp, Affiliated Canc Hosp, Dept Med Oncol, Zhengzhou, Peoples R China;
40.Second Hosp Jilin Univ, Dept Resp Med, Changchun, Jilin, Peoples R China;
41.Peking Union Med Coll Hosp, Dept Resp & Crit Care Med, Beijing, Peoples R China;
42.Dalian Med Univ, Dept Resp Med, Affiliated Hosp 2, Dalian, Peoples R China;
43.China Med Univ, Hosp 1, Dept Pulm & Crit Care Med, Shenyang, Peoples R China;
44.China Japan Friendship Hosp, Dept Resp Dis, Beijing, Peoples R China;
45.Zhejiang Univ, Affiliated Hosp 1, Dept Resp Med, Sch Med, Hangzhou, Peoples R China;
46.Chinese Acad Med Sci & Peking Union Med Coll, Dept Med Oncol, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R China;
47.Hunan Canc Hosp, Thorac Med Dept 2, Changsha, Peoples R China;
48.Shenzhen Peoples Hosp, Dept Resp Med, Shenzhen, Peoples R China;
49.Fujian Prov Hosp, Dept Resp Med, Fuzhou, Peoples R China;
50.Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Pulm & Crit Care Med, Wuhan, Peoples R China;
51.First Hosp Qinhuangdao, Dept Resp & Crit Care Med, Qinhuangdao, Hebei, Peoples R China;
52.China Med Univ, Dept Resp Med, Shengjing Hosp, Shenyang, Peoples R China;
53.Xi An Jiao Tong Univ, Dept Resp Med, Affiliated Hosp 2, Xian, Peoples R China;
54.900th Hosp Joint Logist Support Force, Dept Pulm & Crit Care Med, PLA, Fuzhou, Peoples R China;
55.Fourth Mil Med Univ, Xijing Hosp, Dept Pulm & Crit Care Med, Xian, Peoples R China;
56.Kunming Med Univ, Affiliated Hosp 1, Dept Resp & Crit Care Med 2, Kunming, Yunnan, Peoples R China;
57.Zhengzhou Univ, Henan Prov Peoples Hosp, Peoples Hosp, Dept Resp & Crit Care Med, Zhengzhou, Peoples R China;
58.Cent South Univ, Xiangya Hosp, Dept Med Oncol, Changsha, Peoples R China;
59.Tianjin Med Univ Gen Hosp, Dept Med Oncol, Tianjin, Peoples R China;
60.Guangdong Acad Med Sci, Guangdong Lung Canc Inst, Guangdong Prov Peoples Hosp, Guangzhou, Peoples R China;
61.Army Med Univ, Dept Resp Med, Affiliated Hosp 1, Chongqing, Peoples R China;
62.Sun Yat Sen Univ, Affiliated Hosp 1, Dept Resp & Crit Care Med, Guangzhou, Peoples R China;
63.Third Mil Med Univ, Chongqing Key Lab Immunotherapy, Xinqiao Hosp, Chongqing, Peoples R China;
64.Fudan Univ, Dept Radiat Oncol, Shanghai Canc Ctr, Shanghai, Peoples R China;
65.Fudan Univ, Dept Pulm Med, Zhongshan Hosp, Shanghai, Peoples R China;
66.Cent South Univ, Xiangya Hosp, Dept Pulm Med, Changsha, Peoples R China;
67.Sichuan Univ, West China Hosp, Clin Res Ctr Resp Dis, Dept Resp & Crit Care Med, Chengdu, Peoples R China;
68.Jinling Hosp, Dept Resp & Crit Care Med, Nanjing, Jiangsu, Peoples R China;
69.Zhejiang Univ, Dept Resp Dis, Affiliated Hosp 1, Coll Med, Hangzhou, Zhejiang, Peoples R China;
70.Shanghai Chest Hosp, Dept Pulmonol, Shanghai, Peoples R China;
71.Semmelweis Univ, Dept Pulmonol, Budapest, Hungary;
72.Pompeu Fabra Univ UPF, Inst Salud Carlos III, CIBER Enfermedades Resp,Dept Med & Life Sci MELIS, Pulmonol Dept,Lung Canc & Muscle Res Grp,IMIM Hos, Parc Salut Mar, Barcelona, Spain;
73.Sungkyunkwan Univ, Dept Med, Samsung Med Ctr, Div Pulm & Crit Care Med,Sch Med, Seoul, South Korea;
74.IRCCS European Inst Oncol, Div Thorac Surg, Milan, Italy;
75.Univ Milan, Dept Oncol & Hematooncol, Milan, Italy;
76.Teikyo Univ, Dept Surg, Sch Med, Tokyo, Japan;
77.Yamanashi Cent Hosp, Lung Canc & Resp Dis Ctr, Yamanashi, Japan;
78.Japanese Red Cross Maebashi Hosp, Dept Gen Thorac Surg, Maebashi, Gunma, Japan;
79.IRCCS Ist Romagnolo Studio Tumori IRST Dino Amado, Meldola, Italy;
80.IRCCS Azienda Osped Univ Bologna, Dept Cardiothorac Surg & Hearth & Lung Transplant, Bologna, Italy;
81.Niigata Univ, Dept Resp Med & Infect Dis, Grad Sch Med & Dent Sci, Niigata, Japan;
82.Univ Campania Luigi Vanvitelli, Thorac Surg Unit, Naples, Italy;
83.Jikei Univ, Dept Surg, Div Thorac Surg, Sch Med, Tokyo, Japan;
84.Saitama Med Univ, Dept Gen Thorac Surg, Int Med Ctr, Saitama, Japan;
85.Univ Politecn Marche, Clin Oncol, Azienda Osped Univ Marche, Ancona, Italy;
86.401 Gen Mil Hosp, Dept Oncol, Athens, Greece;
87.Inst Curie, Inst Thorax Curie Montsouris, Paris, France;
88.UVSQ, Paris Saclay, Versailles, France;
89.IQVIA, Therapeut Sci & Strategy Unit, Oncol Ctr Excellence, Milan, Italy;
90.European Inst Oncol IRCCS, Div Thorac Oncol, Milan, Italy;
91.Cent Japan Int Med Ctr, Lung Canc Ctr, Minokamo, Japan;
92.Shenzhen Peoples Hosp, Shenzhen Inst Resp Dis, Shenzhen, Peoples R China;
93.Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou Inst Resp Hlth, Guangzhou, Peoples R China
Recommended Citation
GB/T 7714
Zhou, Chengzhi,Qin, Yinyin,Zhao, Wei,et al. International expert consensus on diagnosis and treatment of lung cancer complicated by chronic obstructive pulmonary disease[J]. Translational Lung Cancer Research,2023,12(8):1661-1701.
APA Zhou, Chengzhi.,Qin, Yinyin.,Zhao, Wei.,Liang, Zhenyu.,Li, Min.,...&Chen, Rongchang.(2023).International expert consensus on diagnosis and treatment of lung cancer complicated by chronic obstructive pulmonary disease.Translational Lung Cancer Research,12(8),1661-1701.
MLA Zhou, Chengzhi,et al."International expert consensus on diagnosis and treatment of lung cancer complicated by chronic obstructive pulmonary disease".Translational Lung Cancer Research 12.8(2023):1661-1701.
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Altmetrics Score
Google Scholar
Similar articles in Google Scholar
[Zhou, Chengzhi]'s Articles
[Qin, Yinyin]'s Articles
[Zhao, Wei]'s Articles
Baidu academic
Similar articles in Baidu academic
[Zhou, Chengzhi]'s Articles
[Qin, Yinyin]'s Articles
[Zhao, Wei]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Zhou, Chengzhi]'s Articles
[Qin, Yinyin]'s Articles
[Zhao, Wei]'s Articles
Terms of Use
No data!
Social Bookmark/Share
No comment.
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.